<DOC>
	<DOCNO>NCT00952094</DOCNO>
	<brief_summary>Randomized , open , single ascend dose , parallel study evaluate pharmacokinetics , pharmacodynamics safety KRN1493 single oral administration healthy Korean male volunteer .</brief_summary>
	<brief_title>Pharmacokinetic , Pharmacodynamic Safety Evaluation After Single Oral Administration KRN1493</brief_title>
	<detailed_description>Eligibility participation study determine demographic information , medical history , physical examination , electrocardiogram ( ECG ) clinical laboratory test within 3 week study drug administration . Subjects suitable study admit Clinical Trials Center , Seoul National University Hospital day dose , overnight-fasted 10 p.m. Day -1 . Subjects dose study drug orally 240 ml water around 9 a.m. Day 1 fast 4 hour post-dose . Subjects perform scheduled procedure include clinical laboratory test , electrocardiogram pharmacokinetic sampling . During admission , subject serve low calcium diet . Subjects discharge Day 2 , visit Clinical Trials Center Day 3 , Day 4 Day 5 . Study participation terminate post-study visit ( Day 7 - 10 ) .</detailed_description>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Healthy male subject age 20 35 year A body mass index ( BMI ) range 1927 kg/m2 Sufficient ability understand nature study hazard participate . Provide write informed consent fully inform study procedure . Subject n't drink grapefruit within 3 day prior test drug dosing Subject judge eligible study participation investigator consider screen result except PTH Clinically relevant abnormal medical history could interfere objective study . A subject history gastrointestinal disease surgery ( except simple appendectomy repair hernia ) , influence absorption study drug . Presence history severe adverse reaction drug history severe allergic disease . Presence history drug alcohol abuse . Participation clinical trial within 3 month ( case bioequivalence study clinical trial ) within 4 month ( case phase 1 study ) 1 month ( case patch ) prior schedule study drug administration ( measure final dosing day previous trial ) Use prescription medicine , herbal medicine overthecounter medication within 7 day first dose Use medication food induces inhibit CYP2D6 CYP3A4 within 1 month prior test drug dosing ( except food contain grapefruit ) Loss 400 mL blood 3 month 200ml 1 month study , apheresis 2 week study . Subject judge eligible study participation investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>